Molecular basis for the efficiency of an Akkermansia muciniphila α-1,2-fucosidase on conjugated H and Lewis epitopes
Structure · 2026-11
DOI: 10.1016/j.str.2026.10.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Structure, 2026-11. Verfasst von Mathias Jensen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), 2800 Kongens Lyngby, Denmark. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Gobierno de España Ministerio de Ciencia e Innovación, Independent Research Fund Denmark.
Abstract (Originalsprache)
H and Lewis (Le) antigens mediate host-microbe interactions and are immune-determinants in the ABO blood system. α-1,2-Fucosidases active on these antigens are of considerable interest for glycoengineering applications, notably within transfusion medicine. How α-1,2-fucosidases recognize H and Le antigens remains hitherto unexplored. Here, we use X-ray crystallography, molecular dynamics simulations and mutagenesis to reveal that multiple H and Le antigens of different composition and conformations are recognized by the same subsites in an α-1,2-fucosidase from the mucin-degrader Akkermansia muciniphila. A secondary fucosyl binding subsite, previously not reported in α-fucosidases, was shown to govern catalytic efficiency towards di-fucosylated H type 3 and Le substrates. Mutational analyses indicated that enzyme-glycan interactions beyond the active site modulate catalytic efficiency on conjugated substrates. Our findings highlight unprecedented structural features that underpin catalytic efficiency towards mucosal or cell surface human glycoconjugates, offering a framework for the design of α-1,2-fucosidase tailored for specific biomedical applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), 2800 Kongens Lyngby, Denmark.
- Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), 2800 Kongens Lyngby, Denmark; Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica, Facultat de Farmàcia i Ciències de l'…
- Division of Transfusion Medicine, Department of Laboratory Medicine and Stem Cell Center/Stem Therapy, Lund University, 22100 Lund, Sweden.
- Division of Transfusion Medicine, Department of Laboratory Medicine and Stem Cell Center/Stem Therapy, Lund University, 22100 Lund, Sweden; Department of Clinical Immunology and Transfusion Medicine, Skåne University Ho…
- Departament de Química Inorgaǹica i Orgaǹica (Secció de Química Orgaǹica) and Institut de Química Teor̀ica I Computacional (IQTCUB), Universitat de Barcelona, 08028 Barcelona, Spain; Institució Catalana de Recerca i Est…
- Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), 2800 Kongens Lyngby, Denmark. Electronic address: maah@dtu.dk.
Förderung
- Swedish Research Council
- Gobierno de España Ministerio de Ciencia e Innovación
- Independent Research Fund Denmark
- Novo Nordisk Foundation
- Knut and Alice Wallenberg Foundation
Zitieren
APA
Jensen, M., Corbella, M., Stenfelt, L., Olsson, M. L., Morth, J. P., Rovira, C., & Abou Hachem, M. (2026). Molecular basis for the efficiency of an Akkermansia muciniphila α-1,2-fucosidase on conjugated H and Lewis epitopes. Structure. https://doi.org/10.1016/j.str.2026.10.011
Vancouver
Jensen M, Corbella M, Stenfelt L, Olsson ML, Morth JP, Rovira C, et al. Molecular basis for the efficiency of an Akkermansia muciniphila α-1,2-fucosidase on conjugated H and Lewis epitopes. Structure. 2026. doi:10.1016/j.str.2026.10.011
BibTeX
@article{Jensen2026,
author = {Jensen, Mathias and Corbella, Marina and Stenfelt, Linn and Olsson, Martin L and Morth, Jens Preben and Rovira, Carme and Abou Hachem, Maher},
title = {Molecular basis for the efficiency of an Akkermansia muciniphila α-1,2-fucosidase on conjugated H and Lewis epitopes},
journal = {Structure},
year = {2026},
doi = {10.1016/j.str.2026.10.011}
}
EUVIMED